All terms in GO

Label Id Description
CAK-ERCC2 complex GO_0070516 [A protein complex formed by the association of the cyclin-dependent protein kinase activating kinase (CAK) holoenzyme complex with ERCC2.]
DNA replication factor C core complex GO_0070517 [A protein complex containing three of the five subunits of eukaryotic replication factor C, those corresponding to human p40, p38, and p37.]
alpha4-beta1 integrin-CD53 complex GO_0070518 [A protein complex that consists of an alpha4-beta1 integrin complex bound to membrane protein CD53, a member of the tetraspan family.]
alpha4-beta1 integrin-CD63 complex GO_0070519 [A protein complex that consists of an alpha4-beta1 integrin complex bound to membrane protein CD63, a member of the tetraspan family.]
negative regulation of T cell activation GO_0050868 [Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation.]
positive regulation of imaginal disc growth GO_0045572 [Any process that activates or increases the frequency, rate or extent of imaginal disc growth.]
regulation of imaginal disc growth GO_0045570 [Any process that modulates the frequency, rate or extent of the growth of the imaginal disc.]
GO_0045573 GO_0045573
sterigmatocystin catabolic process GO_0045574 [The chemical reactions and pathways resulting in the breakdown of sterigmatocystin, a carcinogenic mycotoxin produced in high yields by strains of the common molds.]
sterigmatocystin metabolic process GO_0045460 [The chemical reactions and pathways involving sterigmatocystin, a carcinogenic mycotoxin produced in high yields by strains of the common molds.]
basophil activation GO_0045575 [The change in morphology and behavior of a basophil resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the basophil has specifically bound via IgE bound to Fc-epsilonRI receptors.]
granulocyte activation GO_0036230 [The change in morphology and behavior of a granulocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.]
mast cell activation GO_0045576 [The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.]
myeloid leukocyte activation GO_0002274 [A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.]
obsolete poly-gamma-glutamate metabolic process GO_0070500 [OBSOLETE. The chemical reactions and pathways involving poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds.]
regulation of B cell differentiation GO_0045577 [Any process that modulates the frequency, rate or extent of B cell differentiation.]
regulation of B cell activation GO_0050864 [Any process that modulates the frequency, rate or extent of B cell activation.]
poly-gamma-glutamate biosynthetic process GO_0070501 [The chemical reactions and pathways resulting in the formation of poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds.]
negative regulation of B cell differentiation GO_0045578 [Any process that stops, prevents, or reduces the frequency, rate or extent of B cell differentiation.]
capsule poly-gamma-glutamate biosynthetic process GO_0070502 [The chemical reactions and pathways resulting in the formation of poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds, that forms all or part of a bacterial capsule.]